Prostatic Arterial Embolization: Post-Procedural Follow-up
| Autor: | Lucia Fernandes, Hugo Rio Tinto, Jose Pereira, Marisa Duarte, Tiago Bilhim, João Martins Pisco |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Male
medicine.medical_specialty Time Factors medicine.medical_treatment Prostatic Hyperplasia Severity of Illness Index Predictive Value of Tests Prostate Surveys and Questionnaires Severity of illness Humans Medicine Radiology Nuclear Medicine and imaging Embolization Ultrasonography business.industry Arterial Embolization Diagnostic Techniques Urological Prostate-Specific Antigen medicine.disease Embolization Therapeutic Magnetic Resonance Imaging Surgery Urodynamics Prostate-specific antigen Treatment Outcome medicine.anatomical_structure Predictive value of tests Kallikreins Benign prostatic hyperplasia (BPH) Cardiology and Cardiovascular Medicine business Sexual function Biomarkers |
| Zdroj: | Techniques in Vascular and Interventional Radiology. 15:294-299 |
| ISSN: | 1089-2516 |
| DOI: | 10.1053/j.tvir.2012.09.008 |
| Popis: | Prostatic arterial embolization (PAE) gained special attention in the past years as a potential minimally invasive technique for benign prostatic hyperplasia. Treatment decisions are based on morbidity and quality-of-life issues and the patient has a central role in decision-making. Medical therapy is a first-line treatment option and surgery is usually performed to improve symptoms and decrease the progression of disease in patients who develop complications or who have inadequately controlled symptoms on medical treatment. The use of validated questionnaires to assess disease severity and sexual function, uroflowmetry studies, prostate-specific antigen and prostate volume measurements are essential when evaluating patients before PAE and to evaluate response to treatment. PAE may be performed safely with minimal morbidity and without associated mortality. The minimally invasive nature of the technique inducing a significant improvement in symptom severity associated with prostate volume reduction and a slight improvement in the sexual function are major advantages. However, as with other surgical therapies for benign prostatic hyperplasia, up to 15% of patients fail to show improvement significantly after PAE, and there is a modest improvement of the peak urinary flow. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect